Study details
Enrolling now
A Study of BIO 300 and Thoracic Radiation Therapy
Memorial Sloan Kettering Cancer Center
NCT IDNCT07323732ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
25
Study length
about 3 years
Ages
18+
Locations
7 sites in NJ, NY
About this study
This trial is testing whether giving BIO 300 along with radiation therapy can help prevent lung inflammation (pneumonitis) in people with non-small cell lung cancer and interstitial lung disease. The study will last for about a year.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take BIO 300
PhasePhase 2
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Oncology, Respiratory